NormaTec was founded in 1998 by Laura F. Jacobs, MD, PhD in response to a desperate need for new technology to rapidly and non-invasively treat circulation-related disorders.
The Search for Effective Treatment
In the 1990s, as Chief of Physical Medicine and Rehabilitation at a major East Coast academic medical center, Dr. Jacobs saw hundreds of patients with debilitating peripheral vascular diseases. She recognized the powerful potential of external, pneumatic compression, and decided to create a state-of-the-art Pneumatic Compression Device that would achieve the clinical results patients with peripheral vascular disease needed and deserved. In 1998, she founded NormaTec -- an effort to promote Normal Healing through Technology -- and researched the physiological mechanisms needed to significantly improve patient outcomes. In 2002, the company introduced the NormaTec PCD (Pneumatic Compression Device), an FDA-cleared medical device that yields highly effective clinical results for patients with peripheral vascular diseases.
Peristaltic Pulse: A New Approach
The unique core feature of the NormaTec PCD is the patented Peristaltic Pulse pneumatic waveform: a major scientific advance beyond existing inflation and deflation strategies, employing concepts of bio-mimicry and normal physiology. The use of Pneumatic Medicine and the NormaTec PCD provides consistently excellent clinical outcomes for a wide array of peripheral vascular diseases, including chronic wounds, venous insufficiency, and post-mastectomy and other types of lymphedema.
In 2007, NormaTec extended its focus to the Sports Medicine community with the launch of the NormaTec MVP ("Most Valuable Pump"). Top pro and college sports teams like the Buffalo Bills and the Florida Gators, the U.S. Navy SEALS, the Garmin Pro Cycling team, and other serious athletes seeking the best recovery tool are among those already incorporating the NormaTec MVP into their daily protocols.
Since 2004, NormaTec has been based in the medical and technology hub of Boston, MA, growing rapidly to meet prescriber and patient needs nationwide. The company's dedicated professionals include researchers, nurses, engineers, regulatory specialists, and health insurance case managers, all committed to NormaTec's overall mission to provide excellent clinical outcomes with superb equipment, quality customer service and professional support.
Peripheral vascular diseases present enormous challenges to both patients and society, and Pneumatic Medicine will be a key factor in meeting that challenge in the years ahead. NormaTec offers the most advanced and most effective technology to treat these debilitating, costly conditions, and looks forward to continuing to transform the medical approach to peripheral vascular conditions.